These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3760977)

  • 21. Transrectal portal scintigraphy with I123 iodoamphetamine in liver diseases.
    Izuno K; Fujiyama S; Shibata J; Yoshida K; Sato T; Shimomura O; Takahashi M
    Hepatogastroenterology; 1991 Dec; 38 Suppl 1():8-11. PubMed ID: 1668379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Caffeine elimination in cirrhotic and non-cirrhotic liver disease of different etiology.
    Joeres R; Brachtel D; Gallenkamp H; Hofstetter G; Klinker H; Zilly W; Richter E
    Z Gastroenterol; 1993 Feb; 31 Suppl 2():56-61. PubMed ID: 7483716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating adiponectin reflects severity of liver disease but not insulin sensitivity in liver cirrhosis.
    Kaser S; Moschen A; Kaser A; Ludwiczek O; Ebenbichler CF; Vogel W; Jaschke W; Patsch JR; Tilg H
    J Intern Med; 2005 Sep; 258(3):274-80. PubMed ID: 16115302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hepatic gammagraphy in alcoholism. Its relation to digestive radiology].
    Navarro Izquierdo AL; Galbe Sada R; Duque Gallo JJ; Ros Mendoza L; Solsona F
    Rev Esp Enferm Apar Dig; 1984 Dec; 66(6):523-9. PubMed ID: 6522789
    [No Abstract]   [Full Text] [Related]  

  • 25. Scintigraphic right-to-left liver lobe ratio and liver-to-spleen ratio in cirrhosis and non cirrhotic liver diseases.
    Khanna MU; Abraham P; Shikare SS; Tilve GH
    J Assoc Physicians India; 1991 Mar; 39(3):265-7. PubMed ID: 1880097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Distribution of biliary lipids in healthy subjects, in liver cirrhosis, fatty liver and in cholecystitis].
    Erb W; Kautzsch S
    Z Gastroenterol; 1971; 9(6):447-60. PubMed ID: 5164737
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of smoking on caffeine elimination by the liver in patients with chronic liver diseases].
    Hartleb M; Nowak A; Becker A; Mańczyk I
    Pol Arch Med Wewn; 1990 Dec; 84(6):351-6. PubMed ID: 2092323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Regional liver circulation and scintigraphic imaging of portal circulation with 133Xe].
    Kroiss A
    Acta Med Austriaca Suppl; 1984; 31():1-28. PubMed ID: 6599830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis of diffuse hepatocellular diseases using SPECT.
    Kodama T; Watanabe K; Hoshi H; Jinnouchi S; Arakawa K; Kusumoto S; Honda H
    J Nucl Med; 1986 May; 27(5):616-9. PubMed ID: 3486958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrahepatic lesion presenting as an area of increased radiocolloid uptake on a liver scan.
    Coel M; Halpern S; Alazraki N; Ashburn W; Leopold G
    J Nucl Med; 1972 Mar; 13(3):221-2. PubMed ID: 5058242
    [No Abstract]   [Full Text] [Related]  

  • 31. Increased serum activin-A differentiates alcoholic from cirrhosis of other aetiologies.
    Voumvouraki A; Notas G; Koulentaki M; Georgiadou M; Klironomos S; Kouroumalis E
    Eur J Clin Invest; 2012 Aug; 42(8):815-22. PubMed ID: 22304651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of echogenic lesion of focal fatty infiltration in fibrotic liver.
    Nagoshi S; Sato Y; Fujiwara K
    Radiat Med; 1991; 9(3):91-4. PubMed ID: 1924846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Different elimination velocity of indocyanine green in liver diseases of various severity].
    Brügmann E
    Z Gesamte Inn Med; 1973 Sep; 28(17):523-6. PubMed ID: 4767186
    [No Abstract]   [Full Text] [Related]  

  • 34. Blood clearance rate as an adjunct to the 198 Au hepatoscan.
    Bahk YW
    Br J Radiol; 1972 Jan; 45(529):24-30. PubMed ID: 4332734
    [No Abstract]   [Full Text] [Related]  

  • 35. Simple computer quantitation of spleen-to-liver ratios in the diagnosis of hepatocellular disease.
    Wasnich R; Glober G; Hayashi T; Vicher T; Yeh F
    J Nucl Med; 1979 Feb; 20(2):149-54. PubMed ID: 372503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Fatty acid composition of liver lipids in chronic hepatitis, liver cirrhosis and fatty liver].
    Mokhov VM; Bliuzdin IuA
    Vopr Med Khim; 1987; 33(3):38-42. PubMed ID: 3630012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nuclear magnetic resonance imaging of the liver: initial experience.
    Doyle FH; Pennock JM; Banks LM; McDonnell MJ; Bydder GM; Steiner RE; Young IR; Clarke GJ; Pasmore T; Gilderdale DJ
    AJR Am J Roentgenol; 1982 Feb; 138(2):193-200. PubMed ID: 6275694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of various types of liver diseases on the behavior of cefoperazone].
    Malè PJ; Dayer P; Châtelain G; Rudhardt M; Fabre J
    Schweiz Med Wochenschr; 1983 Dec; 113(49):1860-3. PubMed ID: 6676938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myocardial fatty acid metabolism after acute ethanol consumption.
    Höck A; Notohamiprodjo G; Spohr G; Kaiser KP; Freundlieb C; Vyska K; Shreeve WW; Schweitzer H; Feinendegen LE
    Nucl Med Commun; 1986 Sep; 7(9):671-82. PubMed ID: 3774262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Biochemical aspects of alcoholism. IV. Alcohol-induced diseases of the liver].
    Szczepańska-Szewczyk M; Szukalski B
    Postepy Hig Med Dosw; 1989; 43(5-6):541-73. PubMed ID: 2488248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.